PTCT PTC Therapeutics, Inc.
$63.70 +0.08%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+0.08%
YTD
-0.30%
P/E
7.84
P/B
14.29
ROE
-351.9%
Div yield
—
Beta
0.65
Market cap
$5.4B
RSI (14)
39
Next earnings
Oct 22, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$64.53
Close
$63.70
VWAP (n/a)
—
Day high
$65.27
Day low
$62.92
Volume
1.3M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
2026 Philadelphia ORBIE Awards Honor Top Technology and Security Executives in Philadelphia
Yahoo Finance · Sep 28
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance · Sep 25
PTC Completes Acquisition of ST-920 Fabry Disease Gene Therapy
Yahoo Finance · Sep 21
PTC Therapeutics (PTCT) Could Be 36% Undervalued Following Pipeline Progress
Yahoo Finance · Sep 20
PTC Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance · Aug 27
PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety Profile
Yahoo Finance · Aug 24
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Sep 21, 2026 View → 8-K Aug 28, 2026 View → 8-K Aug 13, 2026 View → 10-Q Jul 30, 2026 View → 8-K Jul 30, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell PTCT. Try it in the Lab to size a position and see the risk.